Most antibiotics trace their origins to living organisms, primarily soil-dwelling bacteria and fungi that produce antimicrobial compounds as part of their natural chemistry. The penicillin you take for a throat infection descends from a mold; the erythromycin prescribed for a lung infection comes from a soil bacterium. Over the past century, chemists have learned to modify these natural molecules and, in some cases, build entirely new ones from scratch. So the full answer to “what are antibiotics made of” spans a surprisingly wide spectrum, from dirt and deep-sea mud to computer-designed molecules that have never existed in nature.
Soil Bacteria and the Roots of Most Antibiotics
If you had to pick a single source responsible for the largest share of clinical antibiotics, it would be a group of soil bacteria called Streptomyces. These microorganisms are prolific chemical factories, churning out a remarkable variety of biologically active compounds, including not just antibiotics but also antifungals, antivirals, and even anti-tumor agents.1The Brazilian Journal of Infectious Diseases. Antibiotics produced by Streptomyces Many of the antibiotic classes that transformed medicine in the mid-twentieth century, including tetracyclines, aminoglycosides, and macrolides, were originally isolated from Streptomyces species found in ordinary soil samples. Researchers have also begun isolating Streptomyces from less obvious places, including traditional medicinal preparations, hoping to find new chemical structures that could form the basis of a next generation of drugs.2PubMed Central. Streptomyces from traditional medicine: sources of new innovations in antibiotic discovery
Fungi have their own celebrated place in this story. Penicillin, the antibiotic that launched the modern era, was famously derived from the Penicillium mold. Other fungal species have contributed cephalosporins and griseofulvin. But in terms of sheer volume and diversity of compounds, bacteria, and Streptomyces in particular, dominate the antibiotic supply chain.
The search for natural antibiotics has also pushed into more exotic environments. Deep-sea microorganisms, adapted to extreme pressures, temperatures, and chemical conditions, have shown the ability to produce novel compounds with potent biological activity.3PubMed Central. Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives The logic is straightforward: organisms that evolved under unusual stress may have developed unique chemical defenses. Researchers have sampled hydrothermal vents, deep ocean sediments, and even organisms living in polar ice, all in pursuit of molecules that look and act differently from what’s already been found on land.
Why Microbes Bother Making Antibiotics at All
It’s easy to assume that bacteria and fungi produce antibiotics purely as weapons, killing off competitors to claim territory and food. That picture is partly true but too simple. In the soil, where these compounds evolved over billions of years, antibiotics are often present at concentrations far below what would kill a rival microbe. At those low levels, they appear to function more like signaling molecules, influencing how neighboring organisms behave, communicate, and organize.4PubMed Central. The multifaceted roles of antibiotics and antibiotic resistance in nature
Some antibiotics at sub-lethal concentrations trigger biofilm formation, the process by which bacteria build communal structures on surfaces. Others modulate the production of virulence factors or influence how bacteria interact with host cells. For the producing organism, these compounds may also serve internal purposes, such as acquiring scarce nutrients from the environment or switching the bacterium into a dormant survival mode when conditions deteriorate.5PubMed. Diversity and natural functions of antibiotics produced by beneficial and plant pathogenic bacteria The point matters because it tells us something about the raw materials we’re working with: natural antibiotics were not designed by evolution to serve as human medicine. They evolved in complex ecological networks, which is why repurposing them for clinical use so often requires chemical modification.
From Mold Juice to Medicine: Semi-Synthetic Antibiotics
The vast majority of antibiotics prescribed today are not used in the exact chemical form that a microbe produces. Instead, they are semi-synthetic: a natural molecule serves as the starting scaffold, and chemists alter specific parts of its structure to make it more effective, more stable, or harder for resistant bacteria to defeat.
Penicillin provides the best-known example of how this works. The natural penicillin G produced by Penicillium mold is broken down by an enzyme called penicillin G acylase, yielding a core building block known as 6-APA. That core molecule is the foundation on which chemists attach different chemical side chains to create the many penicillin variants you see in pharmacies: amoxicillin, ampicillin, methicillin, and others.6PubMed Central. Research progress on immobilized penicillin G acylase and industrial applications Each side chain changes the drug’s behavior. Some improve absorption in the gut so you can take a pill instead of receiving an injection. Others widen the range of bacteria the drug can kill. Still others resist the enzymes that bacteria produce to destroy penicillin-class drugs.
This approach extends well beyond penicillins. Cephalosporins, carbapenems, and many tetracyclines all follow the same basic logic: start with a naturally occurring molecule, then tweak its chemistry to solve a specific clinical problem. The advantage is that nature has already done the hardest part, producing a molecule that interacts with bacterial biology in a useful way. The chemist’s job is refinement, not invention from zero.
Fully Synthetic Antibiotics
A smaller but clinically important group of antibiotics owes nothing to nature. These are built entirely in the laboratory using synthetic organic chemistry, without any microbial starting material.
The earliest examples were the sulfonamides, which trace a surprising lineage back to the German dye industry. In the late nineteenth century, advances in dye chemistry opened the door to industrial organic chemistry, and researchers noticed that certain dye compounds had unexpected activity against bacteria. Those observations eventually led to the development of sulfa drugs, the first class of synthetic antibiotics, which preceded penicillin in clinical use.7PubMed. From dyes to drugs: The historical impact and future potential of dyes in drug discovery The connection between textile dyes and life-saving drugs is one of the stranger chapters in medical history.
Fluoroquinolones, including ciprofloxacin and levofloxacin, are another major fully synthetic class. These work by interfering with enzymes bacteria need to copy and maintain their DNA. Because their structures were designed from scratch, they don’t share the chemical vulnerabilities of natural compounds and can often penetrate bacteria that have developed resistance to older drugs.
A more recent addition is the oxazolidinone class, which includes linezolid and tedizolid. Researchers have continued to design novel oxazolidinone structures with different chemical features to improve potency and overcome resistance.8PubMed Central. Design, Synthesis, and Antibacterial Evaluation of Oxazolidinones with Fused Heterocyclic C-Ring Substructure Oxazolidinones work by blocking the bacterial machinery that assembles proteins, a mechanism distinct from nearly every older antibiotic class. That novelty made them especially valuable against drug-resistant infections like MRSA and vancomycin-resistant enterococci.
How Antibiotics Are Manufactured at Scale
Whether the starting material is natural or synthetic, turning an antibiotic into a finished pill or injection involves several industrial steps. For fermentation-derived antibiotics, the process typically consists of fermentation, removal of biomass, solvent extraction, and crystallization.9Separation and Purification Technology. Application of ultrafiltration to improve the extraction of antibiotics
In the fermentation stage, the antibiotic-producing microbe is grown in large steel tanks, sometimes holding tens of thousands of liters, filled with a carefully controlled broth of nutrients. Temperature, pH, oxygen levels, and feeding schedules are all monitored to coax the organism into producing maximum amounts of the desired compound. This deep-tank fermentation approach was pioneered during the scale-up of penicillin production in the 1940s and remains the core technique for manufacturing many antibiotics today.
Once fermentation is complete, the broth is a messy mix of bacterial cells, leftover nutrients, and the target antibiotic dissolved or suspended in liquid. The biomass is filtered out, and the antibiotic is extracted using organic solvents, then purified through additional steps like chromatography. Finally, crystallization produces the pure active ingredient, which is the form that gets formulated into tablets, capsules, or injectable solutions.
Even crystallization is not as straightforward as it sounds. The physical properties of the crystals, their size, shape, and water content, affect how the drug dissolves in your body, how stable it is on the shelf, and how it can be processed in manufacturing equipment. Research on antibiotic crystallization continues to refine these properties; for amoxicillin, for instance, scientists have studied how techniques like ultrasound can control the crystal form produced during the conversion from a sodium salt to the final trihydrate product.10PubMed Central. The effect of ultrasound on the crystallization-precipitation process of transforming sodium amoxicillin into amoxicillin trihydrate
For fully synthetic antibiotics, the manufacturing path replaces fermentation with multi-step chemical synthesis. Chemists start with simple, commercially available organic chemicals and build up the antibiotic molecule through a sequence of reactions, each one adding or rearranging atoms. The later purification and formulation steps are similar to those for fermented drugs.
Artificial Intelligence and the Search for New Molecules
The pipeline for discovering new antibiotics has been notoriously slow for decades, with only a handful of genuinely new classes reaching patients since the 1980s. Several modern approaches are attempting to break that drought, and artificial intelligence is arguably the most attention-grabbing.
In a widely cited study, researchers trained a deep learning model to predict which molecules would have antibacterial activity. The model screened existing chemical libraries and identified a compound they named halicin, which was structurally different from all conventional antibiotics yet killed a broad range of dangerous pathogens, including drug-resistant ones. The team then applied the model to a database of over 107 million molecules and identified eight additional antibacterial compounds that were structurally distant from anything currently in clinical use.11PubMed Central. A Deep Learning Approach to Antibiotic Discovery What makes this approach powerful is speed: a neural network can evaluate millions of candidate molecules in hours, a task that would take traditional lab screening years.
Genome mining is another productive avenue. Instead of growing bacteria and testing what they produce, researchers sequence bacterial genomes and look for clusters of genes that encode the molecular machinery for assembling complex compounds. These biosynthetic gene clusters can reveal potential antibiotics that the organism never produces under normal laboratory conditions. In one analysis of Paenibacillus genomes, researchers found 255 such gene clusters, and roughly 87% of them encoded compounds with no known match, suggesting a deep reservoir of undiscovered chemistry.12PubMed Central. Mining biosynthetic gene clusters in Paenibacillus genomes to discover novel antibiotics
Coaxing “Unculturable” Bacteria to Grow
A stubborn problem in antibiotic discovery is that the vast majority of soil bacteria refuse to grow under standard laboratory conditions. You can scoop up a handful of dirt containing thousands of species, but only a tiny fraction will form colonies on a petri dish. That means the chemistry of most environmental microbes has been invisible to researchers for as long as antibiotic hunting has existed.
A device called the iChip was developed to get around this limitation. It works by placing individual bacterial cells into small wells in a plate, sealing the wells with membranes that allow nutrients and growth factors to diffuse in from the surrounding soil, and then incubating the entire device back in the ground. The bacteria “think” they are still in their natural environment, receiving the chemical cues they need to grow, even though they are now isolated and observable.13PubMed. Isolation of Soil Microorganisms Using iChip Technology The iChip dramatically increases the range of species researchers can cultivate, opening access to previously hidden microbial chemistry.14PubMed. In Situ Isolation and Culturing of Recalcitrant Soil Bacteria using an Isolation Chip (iChip) The most famous result so far from this approach is teixobactin, an antibiotic active against drug-resistant Gram-positive bacteria, discovered using an earlier version of the technology.
Synthetic biology offers yet another workaround. When researchers identify a promising gene cluster in a microbe that is difficult to grow or produces only trace amounts of a compound, they can transplant the relevant genes into a more cooperative host organism. Streptomyces species are popular chassis for this purpose because they already possess the cellular machinery needed to express complex natural-product genes.15PubMed Central. A High-Yield Streptomyces Transcription-Translation Toolkit for Synthetic Biology and Natural Product Applications Researchers have also used other bacterial hosts, including Burkholderia gladioli, to produce compounds originally found in distantly related species, such as anti-MRSA antibiotics and anti-tumor polyketides.16PubMed. Heterologous Biosynthesis of Complex Bacterial Natural Products in Burkholderia gladioli In one case, researchers assembled a 34-kilobase gene cluster and expressed it in Streptomyces albus to produce moenomycin A, an antibiotic that works by disrupting how bacteria build their cell walls.17PubMed. Adaptive Optimization Boosted the Production of Moenomycin A in the Microbial Chassis Streptomyces albus J1074
Beyond Traditional Antibiotics
Not everything being developed to fight bacterial infections qualifies as a traditional antibiotic. Two alternative approaches are drawing serious research investment and are worth understanding as part of the broader picture of where antimicrobial compounds come from.
Antimicrobial peptides, or AMPs, are short protein fragments found throughout nature, in the skin secretions of frogs, the blood of horseshoe crabs, the saliva of humans, and essentially every organism with an immune system. These molecules are typically fewer than 100 amino acids long and carry a positive electrical charge that lets them latch onto the negatively charged membranes of bacteria and punch holes in them.18PubMed. Antimicrobial peptides: key components of the innate immune system Because they attack the membrane itself rather than a single enzyme or metabolic pathway, bacteria have a harder time evolving resistance. AMPs show activity against bacteria, fungi, parasites, and viruses, and they are being explored for applications in medicine, food preservation, and agriculture.19PubMed Central. Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields The challenge is making them practical. Natural AMPs tend to be fragile, expensive to produce, and sometimes toxic to human cells at effective doses. Researchers are designing synthetic versions that mimic the structure and mechanism of natural peptides while being more stable and cheaper to manufacture.20PubMed Central. Antimicrobial peptides: natural templates for synthetic membrane-active compounds
Phage-derived lysins take a different route entirely. Bacteriophages are viruses that infect bacteria, and when they are ready to release their offspring from a host cell, they produce enzymes called lysins that tear open the bacterial cell wall. Researchers are now isolating and engineering these lysins, sometimes called enzybiotics, as standalone antibacterial agents.21PubMed Central. Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens The raw material here is viral, not bacterial or fungal, which marks a genuine shift in where we source antimicrobial tools. Lysins are highly specific, typically killing only a narrow range of bacterial species, which could be an advantage: rather than wiping out your gut flora the way broad-spectrum antibiotics do, a lysin might target only the pathogen causing your infection.
Environmental Contamination from Antibiotic Manufacturing
A topic that gets less public attention than resistance but is closely related is what happens when antibiotic production meets the environment. Drug molecules and their breakdown products have been detected in water and soil at meaningful concentrations since the early days of pharmaceutical manufacturing.22PubMed Central. Designing Safer and Greener Antibiotics Antibiotics in the environment are persistent, can accumulate in living organisms, and are toxic to aquatic life.23PubMed. Highly efficient removal of antibiotic rifampicin from aqueous solution using green synthesis of recyclable nano-Fe3O4
The concern goes beyond simple pollution. When bacteria in rivers, lakes, or agricultural soil are chronically exposed to low levels of antibiotics, they face exactly the kind of selection pressure that breeds resistance. This environmental route is increasingly recognized as a contributor to the global resistance crisis, separate from the more familiar pathway of resistance developing inside treated patients. The manufacturing process itself, especially in regions with weaker environmental regulation, can release active antibiotic residues into waterways near production facilities.
Green chemistry initiatives are trying to address the problem from both directions: redesigning antibiotics to break down more quickly after use and improving manufacturing processes to reduce waste. Some researchers are developing new materials, such as magnetic nanoparticles, that can efficiently adsorb and remove antibiotic residues from contaminated water.23PubMed. Highly efficient removal of antibiotic rifampicin from aqueous solution using green synthesis of recyclable nano-Fe3O4 Others are working on photocatalytic membranes built from recycled plastic waste that can degrade antibiotic contaminants under light exposure.24PubMed Central. Scalable and Systematical Conversions of Domestic Wastes to Core–Sheath Nanofibers for Photocatalytic Degradation of Antibiotics The irony is hard to miss: the same compounds that save lives inside the human body can cause ecological damage when they leak into the world outside it, and solving that problem may require as much chemical ingenuity as discovering the drugs in the first place.